Whereas interferon beta 1 (IFNB1)-based antiviral therapies are generally effective to treat viral infections, ZBP1-triggered inflammatory cell death limits the therapeutic efficacy of IFNB1 during coronavirus infection [12]. Here, ZBP1 is linked to viral infectious disease.